Filter posts

Emerging Company Policy Deconstructed: Small Cap Liquidity Reform Act (H.R. 3448)

In a nutshell: This bill, sponsored by Reps. Sean Duffy (R-WI) and John Carney (D-DE), …

Emerging Company Policy Deconstructed: Start-up Jobs and Innovation Act (S. 1658)

In a nutshell: Senators Robert Menendez (D-NJ) and Pat Toomey (R-PA) introduced the Start-up Jobs …

Biotech IPO Boom or Bubble? The Opening Plenary at the BIO Investor Forum

With 31 (and counting) life sciences companies having already placed IPOs on the market within …

Prosensa's IPO and the Value of the BIO Investor Forum

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of …

Driving Innovation in Breast Cancer: Startup Challenge

The Avon Foundation (AF), National Institutes of Health National Cancer Institute (NCI) and Center for …

Scientific American Worldview Scorecard Correlates with International Investment

Biotechnology innovation requires investment, and the Scientific American Worldview Scorecard can predict where investment goes. …

Innovative Companies and Investment Trends in Clean Tech at World Congress

A recent Reuters article says the U.S. biotech sector is picking up steam in 2013 …

Biotech Hall of Fame: Interview with Biotech’s First Investment Banker

Earlier this week, I had the opportunity to discuss biotech’s storied history with Fred Frank, …

Data Exclusivity Protects Innovators and Assures Investors

Biotechnology companies must have some certainty that they can protect their investment in the development …

BIO Technology Transfer Symposium: Funding that First $2 Million

With creative funding schemes picking up steam and nontraditional funders taking an interest in biotech, …